The rising prevalence in GLP-1 agonists for weight control has led to a debate about formats: skin-applied devices versus tablets . Usually , GLP-1 therapies were solely available in tablet form, but https://zoeuikn024937.p2blogs.com/39387593/glp-1-transdermal-delivery-systems-vs-pills-which-best-for-the-patient